The Supreme Court has made several significant rulings recently that are set to impact the healthcare industry in the United States. Legal professionals in healthcare will find the outcomes crucial as they navigate the evolving landscape.
Chevron Deference Overturned
In a pivotal decision, the Supreme Court overturned the Chevron deference in a 6-3 ruling. Established in 1984, the Chevron deference required courts to defer to the judgment of administrative agencies when dealing with vague or ambiguous statutes. The ruling combines two cases, Loper Bright Enterprises v. Raimondo and Relentless, Inc. v. Department of Commerce. While these cases pertain to the fishing industry, their implications extend to healthcare.
According to KFF, the decision hampers the ability of executive agencies to implement laws passed by Congress, as courts are no longer bound to defer to agency expertise where statutes are ambiguous. Key health care protections such as prescription drug affordability in Medicare and eligibility rules for Medicaid beneficiaries could face challenges due to this ruling.
Mifepristone Access Maintained
In another significant ruling, the Supreme Court unanimously decided to uphold the FDA’s regulations on the abortion pill mifepristone. The case was brought by the Alliance for Hippocratic Medicine, challenging the FDA’s approval and relaxed regulations surrounding the drug. Mifepristone, approved in 2000 and subsequently made more accessible (including allowing non-physicians to prescribe it and permitting telehealth prescriptions), is crucial as medication abortions now account for over half of all abortions in the U.S.
Justice Brett Kavanaugh, writing the opinion, emphasized that the plaintiffs lacked the legal standing to sue the FDA. Thus, mifepristone will remain accessible through telehealth and pharmacies, preserving the current landscape of medication abortions.
Emergency Abortions in Idaho
Further, in an unsigned 6-3 decision, the Supreme Court ruled that Idaho hospitals receiving federal funds must allow emergency abortions to stabilize patients, despite the state’s strict abortion ban. This decision temporarily reinstated a lower-court ruling that protected hospitals from prosecution under Idaho’s abortion ban when conducting emergency abortions. This case hinges on the Emergency Medical Treatment and Labor Act (EMTALA), requiring certain hospitals to stabilize or transfer patients needing emergency care. The Biden administration contended that Idaho’s abortion ban conflicted with EMTALA, leading to the federal court’s involvement.
To explore more about these decisions and their implications for the healthcare industry, you can read the original article on MedCity News.